Efficacy of Dapagliflozin & Metformin Vs Sitagliptin & Metformin in New patients with Type 2 Diabetic in HMC Hospital Peshawar

Authors

  • Muhammad Hussain Afridi
  • Muhamamd Naeem Khan
  • Atta Muhammad Khan
  • Muhammad Abbass
  • Qazi Ikram
  • Javaid Hassan
  • Khadija Bibi
  • Shah Zaib

DOI:

https://doi.org/10.47672/ajhmn.916

Keywords:

Efficacy, Dapagliflozin, Metformin, Sitagliptin, Type 2 Diabetes Mellitus, Hmc Hospital

Abstract

Background:  Efficacy of Dapagliflozin in combination with Metformin versus Sitagliptin in type 2 diabetic patients in hayat abad medical complex  hospital Peshawar to check the efficacy of these anti Diabetic drug on patients and  check the results of  these two double combination drug using long tram and short tram treatment check effectiveness, safety side effects.

Purpose: Randomized Measured study in Department of diabetes and Endocrinology HMC Hospital, Peshawar after the hospital ethical committee approval for one year  i.e. 12-11-2017  to 12-12-2018 check the efficy of dapagliflozin in combination with metformin versus sitagliptin local setting.

Methodology: three hundred subjects were selected via Hospital and opd, Patients were randomly divided into two groups. In Group-A, patients were given 100mg q.d sitagliptin plus 850 mg metformin twice a day. In Group-B, patients were given 10mg qd dapagliflozin plus 850mg metformin twice a day. Patients were followed up in OPD for 7/24 weeks. After 7/24 weeks, blood sample was obtained for assessment of HbA1c. Reports were measured and if HbA1c is < 6.0 then efficacy achieved. All this information was recorded on Performa.

Results: the efficacy dapagliflozin and metformin versus sitagliptin and metformin in type 2 diabetes mellitus patients shows that 105(35.5% in Group A and 81(25.5%) in Group-B had efficacy and p value was 0.10.

Conclusion: the study showed that Role of Efficacy of Metformin and Dapagliflozin is not significantly different when compared with Metformin and Sitagliptin in Diabetes Mellitus Type 2 patients.

Downloads

Download data is not yet available.

Author Biographies

Muhammad Hussain Afridi

Assistant professor Diabetes and endocrinology HMC Hospital Peshawar, Pakistan.

Muhamamd Naeem Khan

Assistant Professor Department of Endocrinology Bolan Medical complex Hospital Quetta, Pakistan.

Atta Muhammad Khan

Assistant Professor of Medicine, MTI, LRH, Peshawar, Pakistan.

Muhammad Abbass

Associate Professor of Medicine, MMC hospital Mardan, Pakistan.

Qazi Ikram

Senior consultant medical specialist DHQ hospital Timergira, Pakistan.

Javaid Hassan

Assistant Professor Physiology, Muhammad College of Medicine, Yasin Abad, Budni Road, Peshawar, Pakistan.

Khadija Bibi

Nursing Department S.S diabetes hospital and medical center, Pakistan.

Shah Zaib

Assistant Professor of Medicine, MMC hospital Mardan, Pakistan.

References

Cahn A, Cefalu WT. Clinical considerations for use of initial combination therapy in type 2 diabetes. Diabetes Care. 2016;39(suppl 2):S137-S145. - PMC - PubMed

Hayward RA, Reaven PD, Wiitala WL, et al. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;372(23):2197-2206. - PubMed

Gerstein HC, Miller ME, Ismail-Beigi F, et al. ACCORD Study Group Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. Lancet. 2014;384(9958):1936-1941. - PMC - PubMed

ADVANCE Collaborative Group. Patel A, MacMahon S, Chalmers J. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;2008(358):2560-2572. - PubMed

Ismail-Beigi F, Craven T, Banerji MA, et al. ACCORD Trial Group Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetesanalysis of the ACCORD randomised trial. Lancet. 2010;376(9739):419-430. - PMC - PubMed

Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497. - PubMed

Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304-314. - PMC - PubMed

American Diabetes Association Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033-1046. - PMC - PubMed

Egede LE, Gebregziabher M, Dismuke CE, et al. Medication nonadherence in diabetes longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012;35:2533-2539. - PMC - PubMed

Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218-1224. - PubMed

Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):1140-1149. - PubMed

Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27(2):384-391. - PubMed

Jha AK, Aubert RE, Yao J, Teagarden JR, Epstein RS. Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. Health Aff (Millwood) 2012;31(8):1836-1846. - PubMed

Benner JS, Chapman RH, Petrilla AA, Tang SS, Rosenberg N, Schwartz JS. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. Am J Health Syst Pharm. 2009;66(16):1471-1477. - PubMed

Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120(8):713-719. - PubMed

Balu S, Simko RJ, Quimbo RM, Cziraky MJ. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence. Curr Med Res Opin. 2009;25(11):2765-2775. - PubMed

Hussein MA, Chapman RH, Benner JS, et al. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrollees? A non-randomized, observational, retrospective study. Am J Cardiovasc Drugs. 2010;10(3):193-202. - PubMed

Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62(1):76-87. - PMC - PubMed

Jarab AS, Almrayat R, Alqudah S, et al. Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes. Int J Clin Pharm. 2014;36(4):725-733. - PubMed

Downloads

Published

2022-01-21

How to Cite

Afridi, M. H., Khan, M. N. ., Khan, A. M. ., Abbass, M. ., Ikram, Q. ., Hassan, J. ., … Zaib, S. . (2022). Efficacy of Dapagliflozin & Metformin Vs Sitagliptin & Metformin in New patients with Type 2 Diabetic in HMC Hospital Peshawar. American Journal of Health, Medicine and Nursing Practice, 7(2), 29–33. https://doi.org/10.47672/ajhmn.916

Issue

Section

Articles